Dividend Cizzle Biotechnology Holdings Plc
Equities
PSL
GB00BNG2VN02
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.625 GBp | +4.84% |
|
+4.84% | +4.84% |
| 05/11 | Cizzle Biotechnology Raises Funds via Convertible Loan Note Issue | MT |
| 05/11 | Cizzle Biotechnology announces LOI with leading UK clinical diagnostic group | RE |
EPS & Dividend: Cizzle Biotechnology Holdings Plc
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -0.0244 | -0.00313 | -0.004824 | -0.00559 |
| Distribution rate | - | - | - | - |
| Reference price 2 | 0.0300 | 0.0145 | 0.0195 | 0.0155 |
| Nbr of stocks (in thousands) | 2,53,448 | 3,47,175 | 3,63,842 | 3,96,392 |
| Announcement Date | 21/06/22 | 27/04/23 | 30/04/24 | 30/04/25 |
1GBP in Million2GBP
Estimates
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 0.88% | 0.99% | 39.23x | 4.04x | 5.69x | |
| -.--% | -.--% | 33.98x | 6.47x | 3.36x | |
| -.--% | -.--% | 103.5x | 9.36x | 6.63x | |
| 0.35% | 0.36% | 55.58x | 2.66x | 11.4x | |
| -.--% | -.--% | -22.06x | 15.02x | 6405.73x | |
| - | - | - | - | - | |
| -.--% | -.--% | 41.75x | 41.69x | 6.77x | |
| 0.87% | 0.95% | 28.03x | 2.48x | 2.24x | |
| -.--% | -.--% | 27.09x | 1.49x | 2.1x | |
| Average | 0.26% | 0.29% | 38.39x | 10.40x | 805.49x | |
| Weighted average by Cap. | 0.29% | 0.32% | 43.37x | 8.90x | 670.98x |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition